Submitted by Anonymous (not verified) on 13 June 2025 - 14:02
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised